Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Dana GALLO"'
Autor:
Jorge CASSEB, Adele CATERINO-DE ARAUJO, Marisa A. HONG, Simone SALOMÃO, Dana GALLO, R. Michael HENDRY, Alberto J.S. DUARTE
Publikováno v:
Revista do Instituto de Medicina Tropical de São Paulo, Vol 39, Iss 4, p 213 (1997)
Human immunodeficiency virus (HIV-1)-infected subjects with acquired immunodeficiency syndrome (AIDS) are often infected with multiple pathogens. In particular, HTLV-I and HTLV-II infections have been found more frequently in AIDS patients than in as
Externí odkaz:
https://doaj.org/article/bec48f0b05db46b3b745091f64909589
Autor:
Dana Gallo, George R. Flores, Patricia A. Conrad, Curtis L. Fritz, Grant L. Campbell, Duc J. Vugia, Anne M. Kjemtrup, Martin E. Schriefer
Publikováno v:
The Journal of Infectious Diseases. 175:1432-1439
A seroprevalence and risk factor study of emerging tickborne infectious diseases (Lyme disease, ehrlichiosis, and babesiosis) was conducted among 230 residents of a semirural community in Sonoma County, California. Over 50% of residents reported find
Publikováno v:
Journal of Clinical Microbiology. 32:2046-2049
We evaluated two commercial human T-cell lymphotropic virus (HTLV) Western blot (WB; immunoblot) kits, Cambridge Biotech Corp. (CBC) and Diagnostic Biotechnology Ltd. (DBL). Both methods employ HTLV type I (HTLV-I) viral lysate and rgp21. The DBL WB
Publikováno v:
Journal of Clinical Microbiology. 30:2275-2278
Serum samples from 20 human immunodeficiency virus type 1 (HIV-1)- and 30 HIV-2-infected and 7 dually infected individuals were reacted by using the indirect immunofluorescence assay (IFA) and membrane fluorescence assay in order to determine whether
Autor:
Benenson As, Dana Gallo, Jaime Sepulveda-Amor, Fernando Guerena-Burgueno, Michael S. Ascher, Duc J. Vugia
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 47:127-132
To assess the prevalence of human T cell lymphotropic virus type 1 and 2 (HTLV-1/2) infections among potentially high-risk populations in the city of Tijuana, Mexico, the prevalence of specific antibodies was determined and information on risk behavi
Publikováno v:
Journal of Clinical Microbiology. 34:213-215
Four licensed enzyme immunoassay (EIA) kits for the measurement of antibody to human T-cell lymphotropic virus (HTLV) type 1, one from Organon Teknika Corp. (OTC), one from Cambridge Biotech Corp. (CBC), and two from Abbott Laboratories (the 1993 mod
Publikováno v:
Journal of Clinical Microbiology. 29:2345-2347
We compared the sensitivities of the prototype human T-cell lymphotropic virus type I (HTLV-I)- and HTLV-II-transformed cell lines, MT2 and Mo-T, with that of an HTLV-II-infected cell line, clone 19, established in our laboratory, in the immunofluore
Autor:
Dana Gallo, Anne-Grethe Poulsen, Jakob B. Pedersen, Robert J. Biggar, Olav Larsen, Mads Melbye, Francisco Dias, Peter Aaby
Publikováno v:
International journal of cancer. 76(3)
In 1989, a population-based cohort of persons agedor = 50 years was established in an urban area of Guinea-Bissau, West Africa. Overall, 346 persons were interviewed in detail about risk behaviors and had capillary blood drawn. Among women, 12.4% wer
Autor:
Jorge Casseb, S. Salomao, R. Michael Hendry, Dana Gallo, Alberto José da Silva Duarte, M A Hong
Publikováno v:
Scopus-Elsevier
Autor:
Claudia Goulston, James I. Mullins, Eva Stevens, Carl V. Hanson, Dana Gallo, David Katzenstein
Publikováno v:
The Journal of infectious diseases. 174(4)
Six human immunodeficiency virus (HIV)-positive women were studied weekly over 8 weeks to detect HIV RNA in plasma and cervical secretions and proviral DNA in cervical, vaginal, and cervicovaginal lavage samples by polymerase chain reaction (PCR) amp